You are here

  • Home
  • Archive
  • Volume 20, Issue 3
  • Vitamin K antagonist-experienced patients with a history of stroke/transient ischaemic attack who switched from warfarin to dabigatran increased their rate of recurrent stroke/transient ischaemic attack compared with those on warfarin

Article info

Article menu
Download PDFPDF
Aetiology/Harm
Cohort study
Vitamin K antagonist-experienced patients with a history of stroke/transient ischaemic attack who switched from warfarin to dabigatran increased their rate of recurrent stroke/transient ischaemic attack compared with those on warfarin

Authors

  1. Correspondence to : Dr John W Eikelboom, McMaster University, Hamilton General Hospital, 237 Barton Street East, Hamilton, Ontario, Canada L9K 1H8; eikelbj{at}mcmaster.ca
View Full Text

Citation

Eikelboom JW, Bosch J
Vitamin K antagonist-experienced patients with a history of stroke/transient ischaemic attack who switched from warfarin to dabigatran increased their rate of recurrent stroke/transient ischaemic attack compared with those on warfarin
BMJ Evidence-Based Medicine 2015;20:117.

Publication history

  • First published April 13, 2015.
Online issue publication 
October 25, 2017

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions